Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather VanSeggelen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Therapy Oncolytics|April 28, 2016
Chimeric antigen receptor-engineered T cells as oncolytic virus carriersHeather VanSeggelen, Daniela Gm Tantalo, Arya Afsahi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesJennifer D Bassett, Stephanie L Swift, Heather VanSeggelen, et al.
Journal for Immunotherapy of Cancer|December 18, 2015
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptorsJoanne A Hammill, Heather VanSeggelen, Christopher W Helsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2015
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in MiceHeather VanSeggelen, Joanne A Hammill, Anna Dvorkin-Gheva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2013
Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumorA J Robert McGray, Robin Hallett, Dannie Bernard, et al.
Blood|November 20, 2010
CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cellsJennifer D Bassett, Teng Chih Yang, Dannie Bernard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Therapy Oncolytics|April 28, 2016
Chimeric antigen receptor-engineered T cells as oncolytic virus carriersHeather VanSeggelen, Daniela Gm Tantalo, Arya Afsahi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesJennifer D Bassett, Stephanie L Swift, Heather VanSeggelen, et al.
Journal for Immunotherapy of Cancer|December 18, 2015
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptorsJoanne A Hammill, Heather VanSeggelen, Christopher W Helsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2015
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in MiceHeather VanSeggelen, Joanne A Hammill, Anna Dvorkin-Gheva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2013
Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumorA J Robert McGray, Robin Hallett, Dannie Bernard, et al.
Blood|November 20, 2010
CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cellsJennifer D Bassett, Teng Chih Yang, Dannie Bernard, et al.
Pageof 1